Literature DB >> 19076825

Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency.

N Rezaei1, A A Amirzargar, Y Shakiba, M Mahmoudi, B Moradi, A Aghamohammadi.   

Abstract

Common variable immunodeficiency (CVID) is a heterogeneous group of primary immunodeficiency diseases. Cytokine production could be affected in CVID patients, whereas its alteration could be due to genetic polymorphisms within coding and promoter regions of the cytokine genes. This study was performed to analyse the proinflammatory cytokine single nucleotide polymorphisms in CVID. The allele and genotype frequencies of a number polymorphic genes coding tumour necrosis factor (TNF)-alpha, interleukin (IL)-1alpha, IL-1beta, IL-1R, IL-1RA and IL-6 were investigated and compared between two groups of CVID patients and controls. The IL-6 GA genotype at position nt565 was significantly over-represented in the patient group (P<0.001), while the IL-6 GG genotype at position -174 (P=0.006) and the GG genotype at position nt565 (P<0.001) were significantly lower than controls. The TNF-alpha AG genotype at position -308 in the patient group was increased significantly in comparison with controls (P=0.027), but the GG genotype at the same position was significantly decreased (P=0.011). IL-6 CA and GA haplotypes were the most frequent haplotypes in the patients (P<0.005), whereas TNF-alpha GA (P=0.002) and IL-6 GG (P<0.001) haplotypes were decreased significantly in the patients in comparison with controls. Cytokine single nucleotide polymorphisms could have a role in pathophysiology of CVID. High production of TNF-alpha is expected in some CVID patients based on the frequency of genotypes/haplotypes of these cytokine gene polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19076825      PMCID: PMC2665675          DOI: 10.1111/j.1365-2249.2008.03790.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Variation in immunoregulatory genes determines the clinical phenotype of common variable immunodeficiency.

Authors:  C G Mullighan; S E Marshall; M Bunce; K I Welsh
Journal:  Genes Immun       Date:  1999-11       Impact factor: 2.676

2.  TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease.

Authors:  C G Mullighan; G C Fanning; H M Chapel; K I Welsh
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

3.  Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes.

Authors:  S C Hoffmann; E M Stanley; E Darrin Cox; N Craighead; B S DiMercurio; D E Koziol; D M Harlan; A D Kirk; P J Blair
Journal:  Transplantation       Date:  2001-10-27       Impact factor: 4.939

4.  Alterations in interleukin secretion (IL-2 and IL-4) by CD4 and CD4 CD45RO cells from common variable immunodeficiency (CVI) patients.

Authors:  J M Ferrer; J Iglesias; M Hernández; N Matamoros
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

5.  Presence of Idiopathic Thrombocytopenic Purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency.

Authors:  Asghar Ramyar; Asghar Aghamohammadi; Kasra Moazzami; Nima Rezaei; Mehdi Yeganeh; Taher Cheraghi; Nima Pouladi; Golnaz Heydari; Hassan Abolhassani; Ali Akbar Amirzargar; Nima Parvaneh; Mostafa Moin
Journal:  Iran J Allergy Asthma Immunol       Date:  2008-09       Impact factor: 1.464

6.  Proinflammatory cytokine gene polymorphisms among Iranian patients with asthma.

Authors:  Seyed Alireza Mahdaviani; Nima Rezaei; Batoul Moradi; Shahin Dorkhosh; Ali Akbar Amirzargar; Masoud Movahedi
Journal:  J Clin Immunol       Date:  2008-09-02       Impact factor: 8.317

7.  Evidence that defective gamma interferon production in patients with primary immunodeficiencies is due to intrinsic incompetence of lymphocytes.

Authors:  R Paganelli; M R Capobianchi; B Ensoli; G P D'Offizi; J Facchini; F Dianzani; F Aiuti
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

8.  In patients with common variable immunodeficiency, interleukin-6 and expression of its receptor on B-cells are normal.

Authors:  U Junker; B vd Heyden-Rynsch; C Diener; H Vogelsang; L Jäger
Journal:  Cell Biol Int       Date:  1993-06       Impact factor: 3.612

9.  Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency--possible immunologic and clinical consequences.

Authors:  P Aukrust; E Lien; A K Kristoffersen; F Müller; C J Haug; T Espevik; S S Frøland
Journal:  Blood       Date:  1996-01-15       Impact factor: 22.113

10.  Decreased levels of total and reduced glutathione in CD4+ lymphocytes in common variable immunodeficiency are associated with activation of the tumor necrosis factor system: possible immunopathogenic role of oxidative stress.

Authors:  P Aukrust; A M Svardal; F Müller; B Lunden; R K Berge; S S Frøland
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

View more
  19 in total

1.  T-helper 1, T-helper 2, and T-regulatory cytokines gene polymorphisms in irritable bowel syndrome.

Authors:  Elham Barkhordari; Nima Rezaei; Mahdi Mahmoudi; Pegah Larki; Hamid Reza Ahmadi-Ashtiani; Bita Ansaripour; Maryam Alighardashi; Mohammad Bashashati; Ali Akbar Amirzargar; Naser Ebrahimi-Daryani
Journal:  Inflammation       Date:  2010-10       Impact factor: 4.092

2.  Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus.

Authors:  Arezou Rezaei; Vahid Ziaee; Fatemeh Tahghighi Sharabian; Sara Harsini; Maryam Mahmoudi; Samaneh Soltani; Maryam Sadr; Mohammad Hassan Moradinejad; Yahya Aghighi; Nima Rezaei
Journal:  Clin Rheumatol       Date:  2015-01-30       Impact factor: 2.980

3.  Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients.

Authors:  Naicui Zhai; Xiumei Chi; Tianyang Li; Hongxiao Song; Haijun Li; Xia Jin; Ian Nicholas Crispe; Lishan Su; Junqi Niu; Zhengkun Tu
Journal:  Cell Mol Immunol       Date:  2014-12-22       Impact factor: 11.530

4.  Significance of IL-1RA Polymorphism in Iranian Patients with Inflammatory Bowel Disease.

Authors:  Nasser Ebrahimi Daryani; Maryam Sadr; Shirin Moossavi; Sepideh Shahkarami; Samaneh Soltani; Elham Farhadi; Nima Rezaei
Journal:  Dig Dis Sci       Date:  2014-12-03       Impact factor: 3.199

5.  Malassezia Yeast and Cytokine Gene Polymorphism in Atopic Dermatitis.

Authors:  Charu Jain; Shukla Das; V G Ramachandran; Rumpa Saha; S N Bhattacharya; Sajad Dar
Journal:  J Clin Diagn Res       Date:  2017-03-01

6.  Mannose-binding lectin polymorphisms in common variable immunodeficiency.

Authors:  Asghar Aghamohammadi; Farshad Foroughi; Nima Rezaei; Saeid Dianat; Ghasem Solgi; Ali Akbar Amirzargar
Journal:  Clin Exp Med       Date:  2009-05-01       Impact factor: 3.984

7.  Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome.

Authors:  Elham Barkhordari; Nima Rezaei; Bita Ansaripour; Pegah Larki; Maryam Alighardashi; Hamid Reza Ahmadi-Ashtiani; Mahdi Mahmoudi; Mohammad-Reza Keramati; Peiman Habibollahi; Mohammad Bashashati; Naser Ebrahimi-Daryani; Ali Akbar Amirzargar
Journal:  J Clin Immunol       Date:  2009-10-21       Impact factor: 8.317

Review 8.  Genetics of hypogammaglobulinemia: what do we really know?

Authors:  Mary Ellen Conley
Journal:  Curr Opin Immunol       Date:  2009-08-03       Impact factor: 7.486

Review 9.  Autoimmunity in common variable immunodeficiency.

Authors:  Shradha Agarwal; Charlotte Cunningham-Rundles
Journal:  Curr Allergy Asthma Rep       Date:  2009-09       Impact factor: 4.806

Review 10.  Primary Immunodeficiencies: Diseases of Children and Adults - A Review.

Authors:  Aleksandra Lewandowicz-Uszyńska; Gerard Pasternak; Jerzy Świerkot; Katarzyna Bogunia-Kubik
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.